Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Cerebrovascular effects of endothelin-1 investigated using high-resolution magnetic resonance imaging in healthy volunteers

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Cerebral metabolism and vascular reactivity during breath-hold and hypoxic challenge in freedivers and healthy controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hybrid PET/MRI imaging in healthy unsedated newborn infants with quantitative rCBF measurements using 15O-water PET

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effect of hypoxia on BOLD fMRI response and total cerebral blood flow in migraine with aura patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Non-invasive methods for measuring vascular changes in neurovascular headaches

    Research output: Contribution to journalReviewResearchpeer-review

  5. Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Current understanding of thalamic structure and function in migraine

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Exploration of physiological and pathophysiological implications of miRNA-143 and miRNA-145 in cerebral arteries

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Calcitonin gene-related peptide - beyond migraine prophylaxis

    Research output: Contribution to journalComment/debateResearchpeer-review

  4. Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Endothelin-1 (ET-1) is a highly potent vasoconstrictor peptide released from vascular endothelium. ET-1 plays a major role in cerebrovascular disorders and likely worsens the outcome of acute ischaemic stroke and aneurismal subarachnoid haemorrhage through vasoconstriction and cerebral blood flow (CBF) reduction. Disorders that increase the risk of stroke, including hypertension, diabetes mellitus, and acute myocardial infarction, are associated with increased plasma levels of ET-1. The in vivo human cerebrovascular effects of systemic ET-1 infusion have not previously been investigated. In a two-way crossover, randomized, double-blind design, we used advanced 3 tesla MRI methods to investigate the effects of high-dose intravenous ET-1 on intra- and extracranial artery circumferences, global and regional CBF, and cerebral metabolic rate of oxygen (CMRO2) in 14 healthy volunteers. Following ET-1 infusion, we observed a 14% increase of mean arterial blood pressure, a 5% decrease of middle cerebral artery (MCA) circumference, but no effects on extracerebral arteries and no effects on CBF or CMRO2. Collectively, the findings indicate MCA constriction secondarily to blood pressure increase and not due to a direct vasoconstrictor effect of ET-1. We suggest that, as opposed to ET-1 in the subarachnoid space, intravascular ET-1 does not exert direct cerebrovascular effects in humans.

Original languageEnglish
JournalJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Pages (from-to)epub
ISSN0271-678X
DOIs
Publication statusE-pub ahead of print - 2019

    Research areas

  • cerebral haemodynamics, Endothelin, endothelium, human, vasoconstriction

ID: 58348930